Effects of Midazolam and Dexmedetomidine on Cognitive Dysfunction Following Open‐Heart Surgery: A Comprehensive Review
Brain and Behavior · 2025-04 · 15 (4)
DOI: 10.1002/brb3.70421 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Brain and Behavior, online erschienen am 09.04.2025. Verfasst von Masoomeh Tabari und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: Dexmedetomidine, Midazolam, Cardiac Surgical Procedures, Cognitive Dysfunction. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Patients undergoing open‐heart surgery often face significant challenges in postoperative cognitive dysfunction (POCD). There has been growing interest in understanding how anesthesia medications, such as dexmedetomidine (DEX) and midazolam, impact cognitive function in these patients.
Method
This comprehensive review aims to detail the effect of DEX and midazolam on cognitive outcomes following open‐heart surgery.
Findings
Midazolam, a highly selective and commonly used benzodiazepine for preoperative anxiolytics and sedation has been associated with POCD. However, evidence regarding its impact on cognitive function is vague; some studies suggest a potential link between midazolam administration and cognitive impairment, while others report no effect or even an improvement in cognitive abilities. DEX is a potential neuroprotective agent in cardiac surgery. The effects of DEX on cognitive function, including a reduction in POCD incidence and severity, have been reported in several studies. It modulates the inflammatory responses, attenuates oxidative stress, and preserves cerebral perfusion. Although DEX and midazolam show promising results, their effects on cognitive function following open‐heart surgery are yet to be elucidated.
Conclusion
Various factors, including patient characteristics, perioperative management, and surgical procedures, may influence these outcomes, highlighting the need for further research to better understand the roles of these agents in cognitive function following open‐heart surgery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
- Clinical Research Development Unit, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.
- Orthopedic Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
- Vascular and Endovascular Surgery Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
ORCID-Profile: Malihe Aghasizadeh
Zitieren
APA
Tabari, M., Moradi, A., Rezaieh, G. A., & Aghasizadeh, M. (2025). Effects of Midazolam and Dexmedetomidine on Cognitive Dysfunction Following Open‐Heart Surgery: A Comprehensive Review. Brain and Behavior, 15(4). https://doi.org/10.1002/brb3.70421
Vancouver
Tabari M, Moradi A, Rezaieh GA, Aghasizadeh M. Effects of Midazolam and Dexmedetomidine on Cognitive Dysfunction Following Open‐Heart Surgery: A Comprehensive Review. Brain and Behavior. 2025;15(4). doi:10.1002/brb3.70421
BibTeX
@article{Tabari2025,
author = {Tabari, Masoomeh and Moradi, Ali and Rezaieh, Golbon Asalforoush and Aghasizadeh, Malihe},
title = {Effects of Midazolam and Dexmedetomidine on Cognitive Dysfunction Following Open‐Heart Surgery: A Comprehensive Review},
journal = {Brain and Behavior},
year = {2025},
volume = {15},
number = {4},
doi = {10.1002/brb3.70421}
}
EUVIMED